About ProteoThera

About company

ProteoThera, Inc. is an early stage biotechnology company that is advancing drug targeting technology. The Company’s transformative platform technology, a proprietary tissue matrix-binding (MB) protein fusion technology, is being developed to improve clinical efficacy and safety of FDA approved and validated therapeutics to create a new paradigm in the treatment of autoinflammatory diseases and in tissue regeneration.